Adjuvant |
supportive therapy applied after initial main treatment. |
Akt |
(protein kinase B), an enzyme that plays a role in cell metabolism, especially the insulin pathway. |
AMPK |
(5′ adenosine monophosphate-activated protein kinase), an enzyme involved in cell metabolism. |
Analogue |
a compound similar in structure to another. |
Angiogenesis |
formation of new blood vessels. |
Apoptosis |
death of cells by a pre-programmed genetic mechanism. |
Autophagy |
a mode of cell death, removing damaged proteins, organelles and pathogens. |
Beta (β)-catenin |
protein that plays a role in cell signaling and cell-cell adhesion. |
Bioavailability |
the proportion of a substance that can be absorbed by the body. |
Biomarker |
a molecule from which a biological process can be identified. |
BMI |
(body-mass index, the body weight in kg divided by the square of the body height in meters), a measure of obesity. |
Cachexia |
late-stage weakness and wasting of the body due to severe illness. |
CA9 |
(carbonic anhydrase-9), an enzyme involved in controlling the body’s acidity. |
Case-control study |
a retrospective study comparing the effect of a given measurable factor on a group of people, compared with a control (non-exposed) group. |
Carcinogenesis |
formation of cancer. |
Caspase-3 |
an enzyme involved in apoptosis. |
Clinical trial |
testing of a drug on humans prior to official approval, beginning with basic toxicity (phase I) and leading to more detailed evaluation on increasing numbers of patients (phases II–IV). |
Cohort study |
a longitudinal (time-course) study testing the effect of a certain treatment on a group of people, normally in comparison with a control (untreated) group. |
Cytokine |
signaling molecule (protein) involved in cell signaling, common in the immune system. |
Desmoplasia |
dense fibrous tissue. |
EGF |
(epidermal growth factor), a protein involved in the growth, proliferation and differentiation of cells. |
EGFR |
(epidermal growth factor receptor), a protein acted upon by epidermal growth factor. |
EMT |
(epithelial-mesenchymal transition), an early event/morphological change in cancer cells becoming invasive. |
Epigenetic |
regulation of gene expression levels. |
Flavonoid |
groups of chemicals, pigments, found in plants that have anti-oxidative and anti-inflammatory properties. |
5-FU |
(5-fluorouracil), a common anti-cancer drug (‘chemotherapy’) often used in combination with other medications. |
FOLFIRINOX |
(folinic acid, fluorouracil, irinotecan and oxaliplatin), a combination chemotherapy drug. |
GPCR |
(G protein-coupled receptor), a protein found on the cell membrane that interacts with incoming signaling molecules. |
Hedgehog |
a signaling mechanism operating in cells, especially during development, and tumorigenesis; sonic hedgehog is a main protein. |
Hydrogel |
cross-linked polymer gel that can absorb and retain water. |
Hyperplasia |
increase in the number of cells within an organ or tissue, forming a barrier. |
IGF |
(insulin-like growth factor), a protein involved in the growth, proliferation and differentiation of cells; shares the same receptor with insulin. |
Intraperitoneal |
an injection into the abdominal cavity of the body. |
Isoform |
a protein with the same function as another but differing slightly in structure. |
Isomers |
a molecule with the same formula but different structure. |
KPC |
a genetically modified mouse model of pancreatic cancer. |
KRAS |
a gene that, when mutated, can cause cells to become cancerous. |
Macrophage |
a type of cell found in the immune system, detects and destroys harmful microorganisms. |
MAPK |
(mitogen associated protein kinase), an enzyme that has a central involvement in the cancer process. |
Meta-analysis |
quantitative study that uses the results of multiple previous analyses to achieve a consensus opinion. |
Microbiome |
microorganisms, especially bacteria, that reside in parts of the body e.g., the gut. |
Neo-adjuvant |
initial therapy applied before the main treatment, e.g., chemotherapy or radiation therapy. |
Neoplasm |
new and abnormal growth of tissue, commonly leading to cancer. |
NF-kB |
(nuclear factor kappa-light-chain-enhancer of activated B cells), a protein involved in gene expression and patho/physiological regulation. |
Notch |
a protein involved in cellular signaling, especially during development, and cancer. |
Orthotopic |
something occurring in its normal location. |
PanIN |
(pancreatic intraepithelial neoplasia), a pathological indicator of pancreatic cancer and its grade. |
PDAC |
(pancreatic ductal adenocarcinoma), the most common type of pancreatic cancer. |
PDX |
(patient derived xenograft), human cancer tissue implanted and surviving in an animal model. |
PI3K |
(phosphoinositide 3-kinase), an enzyme involved in cell signaling. |
Polyphenol |
a type of plant-derived chemical with health benefits. |
Rho-kinase |
a protein/enzyme involved in cell signaling, often as an intermediary. |
STAT3 |
(signal transducer and activator of transcription 3), a protein involved in cell signaling and gene regulation. |
T-cell |
a type of lymphocyte (white blood cell) that is a central part of the immune system. |
TGFβ |
(transforming growth factor beta), a primary signaling protein involved in cellular mechanisms. |
TRAIL |
(tumor necrosis factor-related apoptosis-inducing ligand), a protein that promotes programmed cell death. |
Transgenic |
an organism that contains genetic information from another organism, often used as cancer models. |
Wnt |
(Wingless and Int-1), a signaling mechanism operating in cells, especially during development and tumorigenesis; incorporates a variety of Wnt proteins. |
Xenograft |
a tissue from one species, grafted experimentally to another (often human to mouse). |